Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose and Medilac effects on gut flora and intestinal motility in chronic functional constipation
ChiCTR2000039848Phase 4Recruiting
- Sponsor
- Union Hospital
- Start
- Oct 2020
- Modality
- Small Molecules, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of lactulose and bacillus subtilis + enterococcus faecalis in functional constipation (FC) (2 arms), sponsored by Union Hospital. Primary endpoints: Defecation frequency, Fecal character and 2 more. Started Oct 2020; status: recruiting.
02
Drugs
lactulosebacillus subtilis + enterococcus faecalis
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on ChiCTR2000039848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039848.